Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02654821
What this trial is testing

Study With T-cel Receptor Gene Therapy in Metastatic Melanoma

Who this might be right for
Stage IV Skin MelanomaEye; Melanoma
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00306514
What this trial is testing

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Who this might be right for
Melanoma
Cytos Biotechnology AG
Testing effectiveness (Phase 2)Study completedNCT01708941
What this trial is testing

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Study completedNCT05907122
What this trial is testing

Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

Who this might be right for
Melanoma
Amgen 256
Not applicableEnded earlyNCT04516122
What this trial is testing

Bone Loss in Melanoma Survivors Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8+5 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Looking for participantsNCT06204991
What this trial is testing

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVMelanoma
Inge Marie Svane 10
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650986
What this trial is testing

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Melanoma+47 more
Roswell Park Cancer Institute 15
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT02413827
What this trial is testing

Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma

Who this might be right for
Unresectable Stage III or Stage IV Melanoma
Celldex Therapeutics 9
Not applicableNot Yet RecruitingNCT06093594
What this trial is testing

Investigating Participation Patterns Among Stage IV Melanoma Patients

Who this might be right for
Stage IV Melanoma
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00005610
What this trial is testing

Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 28
Not applicableStudy completedNCT03154190
What this trial is testing

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Who this might be right for
Acute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more
Stanford University 128
Testing effectiveness (Phase 2)Study completedNCT00005961
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00336986
What this trial is testing

Efficacy Study of IL-21 to Treat Metastatic Melanoma

Who this might be right for
CancerMalignant Melanoma
Novo Nordisk A/S 54
Testing effectiveness (Phase 2)Study completedNCT00588341
What this trial is testing

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Who this might be right for
MelanomaSkin CancerCancer
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02156804
What this trial is testing

A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,009
Large-scale testing (Phase 3)Active Not RecruitingNCT01274338
What this trial is testing

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Melanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 1,673
Testing effectiveness (Phase 2)Study completedNCT00003568
What this trial is testing

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Illinois at Chicago
Early research (Phase 1)Study completedNCT01213472
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 33
Next Page